Adacyte Therapeutics is a pioneering company committed to the development and commercialization of unique and innovative therapeutic solutions for the treatment of complex diseases.

our commitment is taking care of your health

      Our genuine interest in patients voice inspires our vision to continue globally developing GMA (Granulocyte-Monocyte Apheresis) as an effective and safe treatment option for IBD and other autoimmune diseases. GMA is today a growing and emerging medical technology which offers a therapeutic alternative to the standard treatments.

Antoni Villaró. Founder & CEO